259 related articles for article (PubMed ID: 1699999)
21. Differential surface expression of class II isotypes on activated CD4 and CD8 cells correlates with levels of locus-specific mRNA.
Diedrichs M; Schendel DJ
J Immunol; 1989 May; 142(9):3275-80. PubMed ID: 2785139
[TBL] [Abstract][Full Text] [Related]
22. Possible involvement of the T4 molecule in T cell recognition of class II HLA antigens: evidence from studies of proliferative responses to SB antigens.
Biddison WE; Rao PE; Talle MA; Goldstein G; Shaw S
J Immunol; 1983 Jul; 131(1):152-7. PubMed ID: 6190904
[TBL] [Abstract][Full Text] [Related]
23. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibodies to murine CD3 epsilon define distinct epitopes, one of which may interact with CD4 during T cell activation.
Portoles P; Rojo J; Golby A; Bonneville M; Gromkowski S; Greenbaum L; Janeway CA; Murphy DB; Bottomly K
J Immunol; 1989 Jun; 142(12):4169-75. PubMed ID: 2470817
[TBL] [Abstract][Full Text] [Related]
25. Differential regulatory role of monomorphic and polymorphic determinants of histocompatibility leukocyte antigen class I antigens in monoclonal antibody OKT3-induced T cell proliferation.
De Felice M; Turco MC; Giarrusso PC; Corbo L; Pizzano R; Martinelli V; Ferrone S; Venuta S
J Immunol; 1987 Oct; 139(8):2683-9. PubMed ID: 2443568
[TBL] [Abstract][Full Text] [Related]
26. Selective signal transduction through the CD3 or CD2 complex is required for class II MHC expression by human T cells.
Oshima S; Eckels DD
J Immunol; 1990 Dec; 145(12):4018-25. PubMed ID: 1979584
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical analysis of HLA class II antigens and tumor infiltrating mononuclear cells in renal cell carcinoma: correlation with clinical and histopathological data.
Brasanac D; Marković-Lipkovski J; Hadzi-Djokić J; Müller GA; Müller CA
Neoplasma; 1999; 46(3):173-8. PubMed ID: 10613593
[TBL] [Abstract][Full Text] [Related]
28. HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens.
Mann DL; Read-Connole E; Arthur LO; Robey WG; Wernet P; Schneider EM; Blattner WA; Popovic M
J Immunol; 1988 Aug; 141(4):1131-6. PubMed ID: 2840463
[TBL] [Abstract][Full Text] [Related]
29. Evidence for a new HLA determinant that causes T cell activation without costimulation.
Mittler RS; Fifer CA; Burbach P; Edinger K; Kiener PA
J Immunol; 1990 Aug; 145(3):794-803. PubMed ID: 1695645
[TBL] [Abstract][Full Text] [Related]
30. Activated T cells and monocytes have characteristic patterns of class II antigen expression.
Robbins PA; Maino VC; Warner NL; Brodsky FM
J Immunol; 1988 Aug; 141(4):1281-7. PubMed ID: 3135327
[TBL] [Abstract][Full Text] [Related]
31. Enhancing effect of anti-HLA class I monoclonal antibodies on T cell proliferation induced via CD2 molecule.
Turco MC; de Felice M; Corbo L; Giarrusso PC; Yang SY; Ferrone S; Venuta S
J Immunol; 1988 Oct; 141(7):2275-81. PubMed ID: 3262654
[TBL] [Abstract][Full Text] [Related]
32. [Functional difference between HLA-DR and HLA-DQ molecules in mixed lymphocyte reaction].
Fujisawa K
Fukuoka Igaku Zasshi; 1989 Jan; 80(1):49-59. PubMed ID: 2524437
[TBL] [Abstract][Full Text] [Related]
33. CD4+ CD45R- suppressor-inducer T-cell clones: requirements for cellular interaction, proliferation and lymphokines for the induction of suppression in peripheral blood mononuclear cells.
Pawelec G
Immunology; 1990 Apr; 69(4):536-41. PubMed ID: 1692302
[TBL] [Abstract][Full Text] [Related]
34. In vitro effects of solubilized HLA-DR--role in immunoregulation?
Claus R; Hausmann S; Zavazava N; Walzel H; Schulze HA; Köhler H; Friemel H; Müller-Ruchholtz W
Cell Immunol; 1994 May; 155(2):476-85. PubMed ID: 8181077
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules.
Klohe EP; Watts R; Bahl M; Alber C; Yu WY; Anderson R; Silver J; Gregersen PK; Karr RW
J Immunol; 1988 Sep; 141(6):2158-64. PubMed ID: 2459201
[TBL] [Abstract][Full Text] [Related]
36. A role of HLA-DQ molecules of stimulator-adherent cells in the regulation of human autologous mixed lymphocyte reaction.
Nieda M; Juji T; Imao S; Minami M
J Immunol; 1988 Nov; 141(9):2975-9. PubMed ID: 2902140
[TBL] [Abstract][Full Text] [Related]
37. Role of human leucocyte antigen DQ in the presentation of T cell epitopes in the major cow's milk allergen alphas1-casein.
Ruiter B; Rozemuller EH; van Dijk AJ; Garssen J; Bruijnzeel-Koomen CA; Tilanus MG; Knol EF; van Hoffen E
Int Arch Allergy Immunol; 2007; 143(2):119-26. PubMed ID: 17228168
[TBL] [Abstract][Full Text] [Related]
38. Differential inhibition of human antigen-specific T cell clone proliferative responses by distinct monoclonal anti-HLA-DR antibodies.
Triebel F; Missenard-Leblond V; Couty MC; Charron DJ; Debre P
J Immunol; 1984 Apr; 132(4):1773-8. PubMed ID: 6199412
[TBL] [Abstract][Full Text] [Related]
39. Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY.
Szöllósi J; Horejsí V; Bene L; Angelisová P; Damjanovich S
J Immunol; 1996 Oct; 157(7):2939-46. PubMed ID: 8816400
[TBL] [Abstract][Full Text] [Related]
40. Generation of self HLA-DR-specific CD3+CD4-CD8+ cytotoxic T cells in chronic graft-versus-host disease.
Yamamoto M; Sugihara K; Ohtsuki F; Tsujino Y; Tanaka A; Kamiya T; Wada H; Kanamaru A; Hara H; Yano A
Bone Marrow Transplant; 1994 Oct; 14(4):525-33. PubMed ID: 7858527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
